Press Release: F2G and Shionogi Announce Positive Topline Results From Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients With Invasive Aspergillosis
MANCHESTER, United Kingdom and OSAKA, Japan, June 18, 2026 (GLOBE NEWSWIRE) -- F2G Ltd and Shionogi & Co., Ltd (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D) (“Shionogi”) today announced positive topline results from the global Phase 3 OASIS study (NCT05101187), comparing the investigational oral antifungal drug olorofim versus AmBisome® (liposomal amphotericin B…
Bank of Spain-regulated card issuer combines human-led and agentic AI pentesting to surface business logic risk and meet regulatory traceability requirements Bank of Spain-regulated card issuer combines human-led and agentic AI pentesting to surface business logic risk and meet regulatory traceability requirements
Þann 12. mars 2026 var tilkynnt um undirritun Sýnar hf. (Sýn) og Ása hf. (Ása) á skilmálaskjali um kaup Ása á vef- og útvarpsmiðlum Sýnar. Frestur samkvæmt skilmálaskjalinu til að ljúka gerð endanlegs kaupsamnings og annarrar nauðsynlegrar skjalagerðar er nú liðinn án þess að kaupsamningur hafi verið undirritaður. Samkomulag um einkarétt Ása til samningaviðræðna er…